GlassScriptPhysician profile
Ayman Fath
NPI 1548723125
$17,461.36
in general payments reported to CMS, 2019-2025
7 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $66.67 · 2023: $195 · 2024: $430 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $14K · Food and Beverage: $1,907 · Travel and Lodging: $1,805 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $13,500.00 |
| Food and Beverage | $1,907.04 |
| Travel and Lodging | $1,804.90 |
| Education | $182.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,462.29 | 2025 | Xience V, Optis, Xience Skypoint |
| Medtronic, INC. | $357.64 | 2022-2025 | Resolute Onyx, Ffrangio |
| E.R. Squibb & Sons, L.L.C. | $250.05 | 2024 | Camzyos |
| Boston Scientific Corporation | $147.83 | 2023 | Watchman Flx |
| Amgen INC. | $100.00 | 2024 | Repatha |
| Janssen Scientific Affairs, LLC | $80.15 | 2024 | Xarelto |
| Lantheus Medical Imaging, INC. | $63.40 | 2023-2025 | Definity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Fath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.